688091 Shanghai Yizhong Pharmaceutical
- 42.97
- -3.02-6.57%
Shanghai Yizhong Pharmaceutical News
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the inclusion of the core product injectable paclitaxel polymer micelles in the national medical insurance catalogue
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on adjusting the upper limit of share repurchase prices and extending the implementation period
Announcement of Resolutions of the Eighth Meeting of the Second Board of Directors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong: Announcement of the progress of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding
Announcement of the progress of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Shanghai Yizhong: Announcement of Resolutions of the 7th Meeting of the 2nd Supervisory Committee of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong: Report of Shanghai Yizhong Pharmaceutical Co., Ltd. for the third quarter of 2024
Shanghai Yizhong: Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Announcement of Resolutions of the 7th Meeting of the 2nd Board of Directors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Announcement of Resolutions of the 7th Meeting of the 2nd Board of Supervisors of Shanghai Yizhong Pharmaceutical Co., Ltd.
Shanghai Yizhong: Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on Obtaining a Notice of Approval for Drug Clinical Trials
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on obtaining a notice of approval for drug clinical trials
Announcement of the progress of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on holding a 2024 semi-annual results briefing
Opinions of Guojin Securities Co., Ltd. on the initial public offering of some restricted shares by Shanghai Yizhong Pharmaceutical Co., Ltd. on the listing and circulation
Announcement of the progress of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of the company\'s shares through centralized bidding transactions
Announcement on the initial public offering of some restricted shares of Shanghai Yizhong Pharmaceutical Co., Ltd.
Announcement of Shanghai Yizhong Pharmaceutical Co., Ltd. on the first repurchase of the company\'s shares through centralized bidding
Repurchase Report of Shanghai Yizhong Pharmaceutical Co., Ltd. on the repurchase of shares through centralized bidding
Analysis
Price Target
No Data
No Data